Steve Jobs is not suffering from cancer

Here is a suggestion for a statement that Apple could issue on Monday to end the speculation about Steve Jobs’ health:

There has been some concern about Steve Jobs’ state of health. Mr Jobs has had intestinal side-effects from his surgery for pancreatic cancer in 2004. Earlier this year, he had minor surgery relating to this condition and subsequently lost some weight. He is free from cancer and his condition is not life-threatening.

It seems extremely likely, from the hints Apple has allowed to escape, and from Mr Jobs’ conversation with Joe Nocera of the New York Times, that this is the truth. A statement to this effect would reassure investors who have become increasingly worried that Apple’s silence indicates that Mr Jobs is more seriously ill.

Instead, he appears to be suffering some unpleasant but fairly common side effects from the intestinal surgery he underwent in 2004. The good news for Mr Jobs and Apple investors is that his health problems – if this is indeed the case – are chronic and manageable rather than anything worse.

Nocera’s column is highly readable not only because I think he neatly sums up why Apple’s secrecy is misplaced but because he forced Mr Jobs into telling him what was up, albeit off the record. I liked Mr Jobs’ opening gambit:

“This is Steve Jobs,” he began. “You think I’m an arrogant [expletive] who thinks he’s above the law, and I think you’re a slime bucket who gets most of his facts wrong.”

There is also a good summary of what appears to be affecting Mr Jobs’ health and weight here on the Fortune magazine website.

A minor excursion from Apple’s habit of compulsive secrecy would be helpful at this point and could put the matter to rest.

Business blog

Strategy & managing

About this blog Blog guide
This blog is mainly about business and strategy and how and why people who run companies take the decisions that they do.

Most of the time, John Gapper is in New York and Andrew Hill is in London. We occasionally debate business issues between us, but your comments and criticism are welcome.




To comment, please register for free with FT.com and read our policy on submitting comments.

All posts are published in UK time.

Contact andrew.hill@ft.com or john.gapper@ft.com about the Business blog.

See the full list of FT blogs.

About John and Andrew

John Gapper is an associate editor and the chief business commentator of the FT. He has worked for the FT since 1987, covering labour relations, banking and the media. He is co-author, with Nicholas Denton, of All That Glitters, an account of the collapse of Barings in 1995.

Andrew Hill is an associate editor and the management editor of the FT. He is a former City editor, financial editor, comment and analysis editor, New York bureau chief, foreign news editor and correspondent in Brussels and Milan.

Archive

« Jun Aug »July 2008
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031